Patient selection
•
Which cases benefit from low-dose RT (4Gy):
–
FL, MZL, SLL, MCL
–
Predominant symptomatic area
–
W&W with localized progression
–
Debulking of residual >R-chemo before maint R (?)
–
Re-irradiation
–
Proximity of vital organs
–
Frail patients
•
Which cases may need intermediate dose RT (24Gy):
–
When max chance for OR longer duration of control is desirable /
advantageous